These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 18496605)
1. The role of Niemann-Pick C1 - Like 1 (NPC1L1) in intestinal sterol absorption. Turley SD J Clin Lipidol; 2008 Apr; 2(2):S20-S28. PubMed ID: 18496605 [TBL] [Abstract][Full Text] [Related]
2. Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels. Xie P; Zhu H; Jia L; Ma Y; Tang W; Wang Y; Xue B; Shi H; Yu L Atherosclerosis; 2014 Dec; 237(2):609-17. PubMed ID: 25463095 [TBL] [Abstract][Full Text] [Related]
3. Ezetimibe inhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in mice. Xie P; Jia L; Ma Y; Ou J; Miao H; Wang N; Guo F; Yazdanyar A; Jiang XC; Yu L Arterioscler Thromb Vasc Biol; 2013 May; 33(5):920-5. PubMed ID: 23471229 [TBL] [Abstract][Full Text] [Related]
4. Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter. Davis HR; Altmann SW Biochim Biophys Acta; 2009 Jul; 1791(7):679-83. PubMed ID: 19272334 [TBL] [Abstract][Full Text] [Related]
5. Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane. Knöpfel M; Davies JP; Duong PT; Kvaernø L; Carreira EM; Phillips MC; Ioannou YA; Hauser H Biochim Biophys Acta; 2007 Sep; 1771(9):1140-7. PubMed ID: 17689140 [TBL] [Abstract][Full Text] [Related]
6. Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia. Davis HR; Veltri EP J Atheroscler Thromb; 2007 Jun; 14(3):99-108. PubMed ID: 17587760 [TBL] [Abstract][Full Text] [Related]
7. Hepatic Expression of Niemann-Pick C1-Like 1, a Cholesterol Reabsorber from Bile, Exacerbates Western Diet-Induced Atherosclerosis in LDL Receptor Mutant Mice. Yamamoto H; Yamanashi Y; Takada T; Mu S; Tanaka Y; Komine T; Suzuki H Mol Pharmacol; 2019 Jul; 96(1):47-55. PubMed ID: 31064810 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol homeostasis by the intestine: lessons from Niemann-Pick C1 Like 1 [NPC1L1). Davis HR; Basso F; Hoos LM; Tetzloff G; Lally SM; Altmann SW Atheroscler Suppl; 2008 Sep; 9(2):77-81. PubMed ID: 18585981 [TBL] [Abstract][Full Text] [Related]
9. Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters. Valasek MA; Repa JJ; Quan G; Dietschy JM; Turley SD Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G813-22. PubMed ID: 18718997 [TBL] [Abstract][Full Text] [Related]
10. Use of NBD-cholesterol to identify a minor but NPC1L1-independent cholesterol absorption pathway in mouse intestine. Adams MR; Konaniah E; Cash JG; Hui DY Am J Physiol Gastrointest Liver Physiol; 2011 Jan; 300(1):G164-9. PubMed ID: 21071508 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects. Zambrano T; Saavedra N; Lanas F; Caamaño J; Salazar LA Mol Diagn Ther; 2015 Feb; 19(1):45-52. PubMed ID: 25589339 [TBL] [Abstract][Full Text] [Related]
12. Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles. Labonté ED; Howles PN; Granholm NA; Rojas JC; Davies JP; Ioannou YA; Hui DY Biochim Biophys Acta; 2007 Sep; 1771(9):1132-9. PubMed ID: 17442616 [TBL] [Abstract][Full Text] [Related]
17. Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing Kikuchi T; Orihara K; Oikawa F; Han SI; Kuba M; Okuda K; Satoh A; Osaki Y; Takeuchi Y; Aita Y; Matsuzaka T; Iwasaki H; Yatoh S; Sekiya M; Yahagi N; Suzuki H; Sone H; Nakagawa Y; Yamada N; Shimano H Mol Metab; 2016 Nov; 5(11):1092-1102. PubMed ID: 27818935 [TBL] [Abstract][Full Text] [Related]
18. Niemann-Pick C1-Like 1 inhibitors for reducing cholesterol absorption. Zhang R; Liu W; Zeng J; Meng J; Jiang H; Wang J; Xing D Eur J Med Chem; 2022 Feb; 230():114111. PubMed ID: 35063734 [TBL] [Abstract][Full Text] [Related]
19. Transporters as drug targets: discovery and development of NPC1L1 inhibitors. Betters JL; Yu L Clin Pharmacol Ther; 2010 Jan; 87(1):117-21. PubMed ID: 19907422 [TBL] [Abstract][Full Text] [Related]
20. Ezetimibe blocks the internalization of NPC1L1 and cholesterol in mouse small intestine. Xie 谢畅 C; Zhou 周章森 ZS; Li 李钠 N; Bian 卞艳 Y; Wang 王永建 YJ; Wang 王丽娟 LJ; Li 李伯良 BL; Song 宋保亮 BL J Lipid Res; 2012 Oct; 53(10):2092-2101. PubMed ID: 22811412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]